Peptable

Comparison

Exenatide vs Matrixyl

Function

While Exenatide is used for type 2 diabetes treatment to improve glycemic control and modestly reduce body weight through GLP-1–like insulinotropic and glucagonostatic effects6768, Matrixyl is a widely used cosmetic peptide with evidence of stimulating extracellular matrix synthesis and reducing wrinkle appearance in skin-care formulations48.

Mechanism

While Exenatide works as a 39-amino-acid exendin-4 peptide originally isolated from Gila monster venom that acts as a long-acting GLP-1 receptor agonist resistant to DPP-4 degradation67, Matrixyl is a palmitoylated pentapeptide, Pal-Lys-Thr-Thr-Lys-Ser (Pal-KTTKS), that acts as a matrikine, signaling to dermal fibroblasts to increase production of collagen, elastin, fibronectin, and other ECM components4858.

Receptor

Exenatide

GLP-1 receptor (GLP1R) 6780

Matrixyl

Not clearly established in the current dataset.

Organism or Origin

Exenatide

Originally from Heloderma suspectum (Gila monster) venom; now produced synthetically67

Matrixyl

Synthetic lipopeptide derived from a collagen I C-terminal fragment sequence5158

Gene

Exenatide

Not assigned in the current dataset.

Matrixyl

Not assigned in the current dataset.

Summary

Exenatide and Matrixyl are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Exenatide is more often discussed in the realm of Metabolic and endocrine, whereas Matrixyl is more often associated with the realm of Dermatology and aesthetics. They also influence different molecular systems, with Exenatide tracking more closely to GLP-1 receptor while Matrixyl centers more on Extracellular matrix proteins. Exenatide has a more venom-derived origin, while Matrixyl is closer to synthetic design background and their development context also differs, with Exenatide approved while Matrixyl is cosmetic grade. Exenatide takes the form of a linear peptide, whereas Matrixyl is closer to a peptide conjugate, Exenatide carries amidation features, while Matrixyl instead reflects palmitoylation changes; while their sequence patterns also diverge, with Exenatide showing alpha-helical domain features and Matrixyl showing protein-mimetic sequence features.

Sources

67Exendin 4 – Potent GLP-1R agonist - SB PEPTIDE, https://www.sb-peptide.com/project/exendin-4-potent-glp-1r-agonist/
68Glucagon-like peptide-1 analogues: An overview - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC3712370/
80GLP-1 Localisation and Proglucagon Gene Expression in ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC6200298/
48Palmitoyl Pentapeptide-4 - R&D PEPTIDE.ONE, https://rnd.peptide.one/product/palmitoyl-pentapeptide-4-pal-lys-thr-thr-lys-ser/
51[PDF] Acetyl tetrapeptide-5 - SkinMiles, https://skinmiles.com/wp-content/uploads/2017/12/Matriskin-Ingredients.pdf
58[PDF] Safety Assessment of Myristoyl Pentapeptide-4, Palmitoyl ..., https://www.cir-safety.org/sites/default/files/Pentapeptide%20Ingredients.pdf